Cullinan Therapeutics, Inc. (CGEM) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$219.88M | -31.4% |
| 2024 | -$167.38M | -9.3% |
| 2023 | -$153.16M | -237.7% |
| 2022 | $111.21M | +269.6% |
| 2021 | -$65.57M | -26.6% |
| 2020 | -$51.80M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$219.88M | -31.4% |
| 2024 | -$167.38M | -9.3% |
| 2023 | -$153.16M | -237.7% |
| 2022 | $111.21M | +269.6% |
| 2021 | -$65.57M | -26.6% |
| 2020 | -$51.80M | — |